Mazumdar Claire

Insider CIK 2034671 · RLAY Director · BCAX Chief Executive Officer, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-08-10	2026-08-12	10,000	—	$0	110,546	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-08-10	2026-08-12	10,000	$3.79	$37.9K	372,152	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-08-10	2026-08-12	10,000	$27.98	$279.8K	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-08-10	2026-08-12	10,000	—	$0	110,546	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-08-10	2026-08-12	10,000	$27.98	$279.8K	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-08-10	2026-08-12	10,000	$3.79	$37.9K	372,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-07-10	2026-07-14	10,000	—	$0	120,546	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-07-10	2026-07-14	28	$29.68	$831	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-07-10	2026-07-14	9,972	$28.42	$283.4K	362,180	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-07-10	2026-07-14	10,000	$3.79	$37.9K	372,152	SEC↗
RLAY Relay Therapeutics, Inc.	A Award deriv	2026-06-09	2026-06-10	32,947	—	$0	32,947	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-05-18	2026-05-20	15,000	—	$0	146,107	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-05-18	2026-05-20	2,978	$20.35	$60.6K	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-05-18	2026-05-20	15,000	$3.79	$56.9K	377,152	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-05-18	2026-05-20	12,022	$19.96	$240.0K	365,130	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-04-20	2026-04-20	15,000	—	$0	161,107	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-04-20	2026-04-20	15,000	$3.79	$56.9K	377,152	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-04-20	2026-04-20	15,000	$23.61	$354.1K	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-04-16	2026-04-20	7,454	—	$0	130,546	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-04-16	2026-04-20	7,080	—	$0	558,432	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-04-16	2026-04-20	8,226	—	$0	56,684	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-04-16	2026-04-20	7,080	$5.45	$38.6K	362,152	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-04-16	2026-04-20	7,454	$3.79	$28.3K	355,072	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-04-16	2026-04-20	8,226	$4.44	$36.5K	347,618	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-20	2026-03-20	1,596	—	$0	176,107	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-20	2026-03-20	1,596	$3.79	$6.0K	340,988	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-20	2026-03-20	1,596	$18.95	$30.2K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-19	2026-03-20	6,905	—	$0	177,703	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-19	2026-03-20	6,905	$3.79	$26.2K	346,297	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-19	2026-03-20	6,905	$18.78	$129.7K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-18	2026-03-20	6,499	—	$0	184,608	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-18	2026-03-20	6,499	$3.79	$24.6K	345,891	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-18	2026-03-20	6,499	$18.84	$122.4K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-09	2026-03-11	36,766	—	$0	191,107	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-09	2026-03-11	36,766	$3.79	$139.3K	376,158	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-09	2026-03-11	36,766	$19.17	$704.8K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-06	2026-03-06	3,817	—	$0	227,873	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-06	2026-03-06	3,817	$3.79	$14.5K	343,209	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-06	2026-03-06	3,817	$18.75	$71.6K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-05	2026-03-06	1,786	—	$0	231,690	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-05	2026-03-06	1,786	$3.79	$6.8K	341,178	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-05	2026-03-06	1,786	$18.74	$33.5K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2026-03-04	2026-03-06	2,631	—	$0	233,476	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2026-03-04	2026-03-06	2,631	$18.73	$49.3K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2026-03-04	2026-03-06	2,631	$3.79	$10.0K	342,023	SEC↗
BCAX Bicara Therapeutics Inc.	A Award deriv	2026-02-02	2026-02-04	450,000	—	$0	450,000	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2025-12-16	2025-12-18	29,500	—	$0	565,512	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2025-12-16	2025-12-18	29,500	$5.45	$160.8K	339,392	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2025-11-24	2025-11-25	41,163	—	$0	236,107	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2025-11-24	2025-11-25	41,163	$3.79	$156.0K	351,055	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2025-11-24	2025-11-25	41,163	$18.86	$776.3K	309,892	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2025-10-16	2025-10-20	24,103	—	$0	277,270	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2025-10-16	2025-10-20	24,103	$3.79	$91.4K	333,995	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2025-10-16	2025-10-20	24,103	$18.83	$453.9K	309,892	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2025-10-15	2025-10-15	13,289	—	$0	301,373	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2025-10-15	2025-10-15	13,289	$18.84	$250.4K	309,892	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2025-10-15	2025-10-15	13,289	$3.79	$50.4K	323,181	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise deriv	2025-10-13	2025-10-15	11,445	—	$0	314,662	SEC↗
BCAX Bicara Therapeutics Inc.	M Exercise	2025-10-13	2025-10-15	11,445	$3.79	$43.4K	321,337	SEC↗
BCAX Bicara Therapeutics Inc.	S Sale	2025-10-13	2025-10-15	11,445	$18.92	$216.5K	309,892	SEC↗
RLAY Relay Therapeutics, Inc.	A Award deriv	2025-06-09	2025-06-11	421,241	—	$0	421,241	SEC↗